Main Line Rheumatology Becomes Main Line Rheumatology & Osteoporosis

 

FOR IMMEDIATE RELEASE

October 28, 2019 Wynnewood, PA… Gary V. Gordon, MD, FACP, FACR, owner of Main Line Rheumatology practice, and chief of Rheumatology, Lankenau Medical Center, announces that Main Line Rheumatology is now called, Main Line Rheumatology & Osteoporosis.

Only our name has changed! The practice of Main Line Rheumatology & Osteoporosis is still independently owned, and its doctors, staff and office locations at Lankenau Medical Center, and Main Line Health Center, in Broomall remain the same.

Why the practice name change? Dr. Gary Gordon said, “Over the last number of years, we have seen a dramatic rise in the number of osteoporosis patients we see, and patients with osteopenia or other fracture risks. Osteoporosis has become our rheumatology practice’s largest growing sub-medical specialty. Adding “osteoporosis” to Main Line Rheumatology, creates a more defining description of our practice, today.”
Osteoporosis is a common rheumatology disease.

According to recent statistics from the National Osteoporosis Foundation, osteoporosis is responsible for an estimated two million broken bones per year, yet nearly 80 percent of older Americans who suffer bone breaks are not tested or treated for osteoporosis. Approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. One in two women, and up to one in four men over age 50, will break a bone due to osteoporosis.

Dr. Gordon added, “Our doctors and staff are committed to treating our osteoporosis patients. I encourage individuals who have noticeable symptoms (i.e. back pain, fractured or collapsed vertebra, loss of height over time, stooped posture, or a bone that breaks much more easily than expected) to make an appointment with a rheumatologist for diagnosis. Pro-active testing and treatment could stave off fractures, or full-blown disease.”

 

 

It’s Important to Get The Right Diagnosis and Care for Painful Autoimmune Conditions

Many rheumatologic diseases are difficult to sort out in the beginning. New York Times medical writer, Jane Brody, describes polymyalgia, an inflammatory disease affecting muscles and connective tissue in the shoulder/pelvic region, and the overlapping and more serious temporal or giant cell arteritis, involving blood vessels to the scalp and the eyes with potential risk of blindness. Talk to your primary care physician and consider seeing a rheumatologist if you have these symptoms.

https://www.nytimes.com/2019/08/19/well/live/arteritis-autoimmune-conditions.html?rref=collection%2Fsectioncollection%2Fwell&action=click&contentCollection=well%C2%AEion=rank&module=package&version=highlights&contentPlacement=1&pgtype=sectionfront

 

#MainLineRheumatology  #inflammatorydisease #arteritis #rheumatologist

New Hours!

To accommodate our patients, Main Line Rheumatology has increased its hours to better serve you!

LANKENAU MEDICAL CENTER
Monday 9am – 5:30pm
Tuesday and Wednesday 8am- 4pm
Thursday 9am – 4pm
Friday 8am- 4pm

MAIN LINE HEALTH CENTER, Broomall
Tuesday, Wednesday and Friday  9am – 4pm

Main Line Rheumatology Welcomes New Staff Rheumatologist, Hyon Ju Park, MD

Philadelphia, PA May 9, 2019… Main Line Rheumatology is excited to announce that we have added Hyon Ju Park, MD, to our staff of rheumatologists. Dr. Park has an impressive resume. She is board-certified in rheumatology and internal medicine, and certified in clinical densitometry (bone density studies).  Dr. Park graduated Columbia University in 2003 with a degree in biochemistry, and graduated Mount Sinai School of Medicine in New York, in 2007. She completed a residency in Internal Medicine at Barnes Jewish Hospital in St. Louis, Missouri as well as a rheumatology fellowship and additional research fellowship at Washington University in St. Louis, Missouri.

Dr. Park has been an avid contributor to medical publishing including editorials, reviews, case reports and many book chapters. She has a special interest in lupus, vasculitis, and periodic fever syndromes.

Dr. Park is the mother of two children, and her husband is a cancer researcher at the University of Pennsylvania.

Philadelphia TOP DOCTORS 2019 Winners and Still Champions! 

CONGRATULATIONS! Philadelphia magazine awards Gary V. Gordon, MD, FACP, FACR and Thomas Harder, MD, Main Line Rheumatology, TOP DOCTORS 2019!

Main Line Rheumatology has offices at Lankenau Medical Center and Main Line Health Center, in Broomall. In addition to Dr. Gordon and Dr. Harder, our doctors, Amy Lundholm D.O. and Hyon Ju Park, MD, are both board certified in rheumatology and internal medicine. Call 610-896-8400 for an appointment. Follow us on Facebook, Instagram and Twitter.

mainlinerheumatology rheumatology philadelphiamagazine topdoctors2019 #drgaryvgordon garyvgordonmd thomashardermd winners

Your Doctor is Your Partner in Good Health!

“You have effectively given me my life and hope back, and for that I will be immensely and eternally grateful.” – A.B.

When we see a patient who is not feeling well, we listen to them very carefully, discuss, diagnose their condition, and together as “partners”, choose treatment options. Dialogue is important to achieve the best outcome.

Main Line Rheumatology Doctors Awarded 2019 HONOR ROLL, Rheumatology, PA

The practice of Main Line Rheumatology is proud to announce that Healthgrades™ has awarded Gary V. Gordon, MD, FACP, FACR and Thomas Harder MD, the distinction of 2019 HONOR ROLL doctors in the category of Rheumatology, Pennsylvania.

Healthgrades is an online database of doctors, dentists, and hospitals that has over 100 million users and has amassed data on more than three million U.S. healthcare providers. is an online database of doctors, dentists, and hospitals that has over 100 million users and has amassed data on more than three million U.S. healthcare providers. In a recent study, Healthgrades and Yelp proved to be the two most important sites for healthcare professionals.

Lupus and Pregnancy, by Amy Lundholm, DO


Systemic Lupus Erythematosus (SLE)
or Lupus can be associated with gestational hypertension (maternal high blood pressure), preterm birth, intrauterine growth restriction and fetal death. Lupus patients may have abnormal placentation (attachment), which is a major contributor of many pregnancy complications due to reduction in maternal blood flow to the fetus. Despite potential risks, women with SLE can have healthy pregnancies. Women with SLE should have low disease activity for the 6 months prior to conception for the best chance of a successful, healthy pregnancy. The PROMISSE Study was a large multicenter prospective study of pregnant and postpartum SLE patients. The study showed that 26 % of patients had a flare (worsening) during pregnancy, and 24.4% had a flare in the postpartum period. Most of the flares were mild and infrequently required therapy.  Only 6.3% of the patients had severe flares during pregnancy and 1.7% had severe postpartum flares.

Data suggests that the drug, Plaquenil, used during pregnancy was associated with fewer preterm births and less intrauterine growth restriction. Findings also suggest that discontinuation of Plaquenil is associated with higher lupus disease activity during pregnancy.

For SLE patients not looking to conceive, IUDs are considered safe and effective. Other acceptable contraceptive options, when used appropriately, include condoms, progestin (only oral contraceptives) or depo-provera injections. Estrogen-containing contraceptives are contraindicated in the setting of active lupus, as they may flare the disease.

Main Line Rheumatology’s Amy L. Lundholm, DO, is board certified in both rheumatology and internal medicine. Dr. Lundholm holds current membership in the Pennsylvania Osteopathic Medical Association and the American College of Rheumatology. She was chosen as a rheumatology Top Doctor 2018 Main Line Today magazine. To read more about Dr. Lundholm, go to Our Staff.